Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $541.26 | 2 | 73.2% |
| Food and Beverage | $198.15 | 6 | 26.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $702.87 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $19.16 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $17.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $702.87 | 6 | Merck Sharp & Dohme Corporation ($702.87) |
| 2017 | $36.54 | 2 | Novartis Pharmaceuticals Corporation ($19.16) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: ONCOLOGY | ||||||
| 01/07/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $213.57 | General |
| Category: ONCOLOGY | ||||||
| 01/07/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $62.63 | General |
| Category: ONCOLOGY | ||||||
| 01/06/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $327.69 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2017 | Astellas Pharma US Inc | Tarceva (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 04/28/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
About Dr. David Dunning, MD
Dr. David Dunning, MD is a Hematology & Oncology healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508863671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dunning, MD has received a total of $739.41 in payments from pharmaceutical and medical device companies, with $702.87 received in 2019. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($541.26).
Practice Information
- Specialty Hematology & Oncology
- Location Alexandria, VA
- Active Since 07/05/2005
- Last Updated 09/02/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1508863671
Products in Payments
- KEYTRUDA (Biological) $702.87
- KISQALI (Drug) $19.16
- Tarceva (Drug) $17.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Alexandria
Vinni Juneja, Md, MD
Hematology & Oncology — Payments: $35,341
Dr. Bassam Abi-Rached, M.d, M.D
Hematology & Oncology — Payments: $13,951
Dr. Howard Wold, M.d, M.D
Hematology & Oncology — Payments: $9,956
Dr. Hafez Halawani, Md, MD
Hematology & Oncology — Payments: $9,228
Dr. Anastas Provatas, Md, MD
Hematology & Oncology — Payments: $8,801
Dr. Christine Ince, M.d, M.D
Hematology & Oncology — Payments: $6,678